Canagliflozin
4 NDCs across 1 manufacturer|0 Generic,4 Brand
Canagliflozin is used to treat type 2 diabetes mellitus, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Mar 29, 2013, and the first generic was approved Apr 14, 2026. FDA's Orange Book lists 4 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $272 million on Canagliflozin across 256,000 claims for 56,000 beneficiaries.
Canagliflozin is available as 4 NDCs from 1 manufacturer (0 generic, 4 brand), with NADAC prices from $19.11 to $19.12 per EA — a 0% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
4
0G / 4B
Manufacturers
1
competing in market
Price Spread
$19.11 – $19.12
per EA
7d Activity
avg +0.0% WoW · of 4 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing CANAGLIFLOZIN
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
INVOKANA 300 MG TABLET | $19.1197 per EA | 0.00% |
INVOKANA 300 MG TABLET | $19.1197 per EA | 0.00% |
INVOKANA 100 MG TABLET | $19.1089 per EA | +0.02% |
INVOKANA 100 MG TABLET | $19.1089 per EA | +0.02% |
Frequently Asked Questions
What is Canagliflozin used to treat?
Canagliflozin is used to treat type 2 diabetes mellitus, per the National Library of Medicine's MED-RT classification.
When did Canagliflozin become available as a generic?
FDA approved the first generic Canagliflozin (ANDA) on Apr 14, 2026. The Orange Book currently lists 4 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Canagliflozin?
In 2024, Medicare Part D spent $272 million on Canagliflozin across 256,000 claims for 56,000 beneficiaries.
How many Canagliflozin products are on the market?
The Canagliflozin drug market contains 4 NDCs from 1 manufacturer — 0 generic and 4 brand products.
What is the price range for Canagliflozin?
NADAC reference prices for Canagliflozin range from $19.1089 to $19.1197 per EA — a 0% difference between cheapest and most expensive.
Which manufacturers make Canagliflozin?
1 manufacturer lists Canagliflozin in NADAC. Ranked by number of NDCs, the largest are Janssen Pharmaceuticals Inc. (4).
How has the price of Canagliflozin changed recently?
Over the past 7 days, 2 Canagliflozin NDCs rose and 0 fell, with a market-wide average change of +0.0%.